Institutional investors hold a majority ownership of BCR through the 89.75% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended March 2017, these large investors purchased a net $722.1 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MARSHALL WACE NORTH AMERICA LP Bought 527.1 Thousand shares of C R Bard Inc
RENAISSANCE TECHNOLOGIES LLC Bought 447.3 Thousand shares of C R Bard Inc
ALLIANCEBERNSTEIN LP Bought 357.4 Thousand shares of C R Bard Inc